Aktiesnakken — September 2011
-
al magt til de grønne
-
største stigning i mere end et år
-
RTH det er nok neuro der smitter af
-
Repsac, to alternativer saxo eller nordnet
-
det kommer bag på mig at markedet vil handle Neurosearch til en mcap på 600 og Genmab til 1200 mia, når Genmab har 5-6 gange cash, en fabrik, en kæmpe pipeline, et produkt på markedet der giver 80 mill royalties. (det siger jeg)
-
mia=mio (desværre)
-
Biotekmarkedet ER tosset præcis som din værdiangivelse ;0))
så får vi noget ud af det begge
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind